Yelin Lapidot Holdings Management’s Invesco S&P 500 Equal Weight ETF RSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Hold
56,190
2.27% 11
2026
Q1
$10.8M Sell
56,190
-5,200
-8% -$1.03M 2.25% 12
2025
Q4
$11.8M Sell
61,390
-5,400
-8% -$1.03M 2.36% 12
2025
Q3
$12.7M Sell
66,790
-14,720
-18% -$2.74M 2.66% 10
2025
Q2
$14.8M Sell
81,510
-15,950
-16% -$2.75M 2.71% 10
2025
Q1
$16.9M Hold
97,460
3.26% 7
2024
Q4
$17.1M Hold
97,460
2.97% 11
2024
Q3
$17.5M Hold
97,460
2.88% 11
2024
Q2
$16M Buy
97,460
+16,460
+20% +$2.71M 2.82% 11
2024
Q1
$13.7M Buy
81,000
+27,200
+51% +$4.37M 2.82% 9
2023
Q4
$8.49M Hold
53,800
2.05% 14
2023
Q3
$7.64M Buy
+53,800
New +$8.04M 1.88% 16

Other funds holding RSP

Yelin Lapidot Holdings Management's RSP Position: Q2 2026 in Review

Yelin Lapidot Holdings Management held its Invesco S&P 500 Equal Weight ETF (RSP) position steady in Q2 2026 at 56,190 shares worth $12M. The position accounts for 2.27% of the portfolio, ranked #11.

Yelin Lapidot Holdings Management first reported a position in RSP in Q3 2023 and has held it in 12 quarters since. The position peaked at $17.5M in Q3 2024. 1,221 funds tracked by Wall St. Rank hold RSP as of Q2 2026.

  • Yelin Lapidot Holdings Management held 56,190 shares of Invesco S&P 500 Equal Weight ETF worth $12M as of Q2 2026.
  • Yelin Lapidot Holdings Management left its Invesco S&P 500 Equal Weight ETF share count unchanged in Q2 2026.
  • Invesco S&P 500 Equal Weight ETF made up 2.27% of Yelin Lapidot Holdings Management's portfolio in Q2 2026, its #11 holding.
  • Yelin Lapidot Holdings Management first reported a position in Invesco S&P 500 Equal Weight ETF in Q3 2023 and has held it in 12 quarters since.
  • Yelin Lapidot Holdings Management's Invesco S&P 500 Equal Weight ETF position peaked at $17.5M in Q3 2024.
  • 1,221 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight ETF as of Q2 2026.

Based on Yelin Lapidot Holdings Management's 13F filing for Q2 2026, filed 3 Aug 2026.